Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Artisan Pharma logo — Pioneering critical-care therapeutics to enhance patient out...

Artisan Pharma

Pioneering critical-care therapeutics to enhance patient outcomes globally

Founded 2006 United States Waltham, United States 6 employees Series C Total: $85.38M Biotechnology, Health Care +1

General Information

Company Name Artisan Pharma
Founded Year 2006
Location United States Waltham, United States
Employees 6
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Artisan Pharma. To contact Artisan Pharma, visit artisanpharma.net.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Artisan Pharma compare?

A PDF of Artisan Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Artisan Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Artisan Pharma

Artisan Pharma, Inc., is a biopharmaceutical company focused on pioneering critical-care therapeutics to enhance patient outcomes globally. The company's slogan "Pioneering critical-care therapeutics to enhance patient outcomes globally" encapsulates their mission to make a significant impact in the field of healthcare. Founded in 2006 and headquartered in Waltham, Massachusetts, Artisan Pharma specializes in providing critical-care and hospital-based therapeutics to patients, treating physicians, and payors both in the United States and internationally. Artisan Pharma's flagship product is ART-123, a novel recombinant and soluble thrombomodulin designed specifically for treating disseminated intravascular coagulation in sepsis. The company has successfully marketed its products in significant regions including Japan, China, Taiwan, and Korea, demonstrating a global expansion strategy. Moreover, their strategic manufacturing alliance with A-Bio Pharma Pte Ltd enables efficient production and distribution of their groundbreaking therapeutics. In terms of investments, Artisan Pharma secured a notable $3.00M Series C investment on 20 July 2010, attracting major investors such as EDBI, New Leaf Venture Partners, Novaquest Capital Management, and NGN Capital. These investments reflect the attractiveness and potential of the company’s innovative approach to improving critical-care treatment. Overall, Artisan Pharma appears to be in a strong position to continue its impactful work in critical-care therapeutics, while also presenting an intriguing opportunity for potential venture capital partners seeking to invest in the biopharmaceutical industry.

Business keywords: biopharmaceutical company, critical-care therapeutics, hospital-based therapeutics, ART-123, thrombomodulin, disseminated intravascular coagulation, sepsis, pharmaceutical market, strategic manufacturing alliance, A-Bio Pharma Pte Ltd, Waltham, Massachusetts, global patient outcomes, drug development, international expansion

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $3.00M 4
EDBI New Leaf Venture Partners Novaquest Capital Management
EDBI, New Leaf Venture Partners +2
20 Jul 2010
Series B $22.00M 3
EDBI Asahi Kasei NGN Capital
EDBI, Asahi Kasei +1
01 Mar 2010
Debt Financing $6.00M -
20 Jan 2010
Debt Financing $15.38M -
28 Apr 2009
Series A $39.00M 3
EDBI New Leaf Venture Partners NGN Capital
EDBI, New Leaf Venture Partners +1
06 Sep 2006

Artisan Pharma Alternatives & Competitors

Artisan Pharma vs
Archimedes Pharma
Archimedes Pharma United Kingdom

Specialty pharmaceutical company developing therapeutics for the treatment of chronic and debilitati...

Acquired
30 employees
Biotechnology, Health Care
Compare Artisan Pharma vs Archimedes Pharma

FAQ About Artisan Pharma

Pioneering critical-care therapeutics to enhance patient outcomes globally
Artisan Pharma was founded in 2006.
Artisan Pharma is headquartered in Waltham, United States.
Artisan Pharma operates in Biotechnology, Health Care and Health and Wellness. Its work centres on biopharmaceutical company, critical-care therapeutics, hospital-based therapeutics and ART-123.
Artisan Pharma has approximately 6 employees.
Artisan Pharma has completed 5 funding rounds, raising a total of $85.38M. The latest funding stage is Series C.
Top alternatives and competitors to Artisan Pharma include Archimedes Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Artisan Pharma and Archimedes Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Artisan Pharma, https://bouncewatch.com/company/artisan-pharma, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes